Ionis Pharmaceuticals
IONS
IONS
282 hedge funds and large institutions have $2.54B invested in Ionis Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 113 increasing their positions, 70 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
282
Holders Change
-32
Holders Change %
-10.19%
% of All Funds
7.54%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.08%
New
33
Increased
113
Reduced
70
Closed
62
Calls
$71.1M
Puts
$41.2M
Net Calls
+$29.8M
Net Calls Change
+$36.1M
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$34.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$28.2M |
| 3 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$22.3M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$19.8M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$19.7M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$43.7M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$22.6M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$17.5M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$16M |
| 5 |
AG
Artal Group
Luxembourg
|
-$14.2M |
